This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Evolva Sa. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations in Antimicrobial Agents by Glen Dale
Introduction
Glen Dale, an accomplished inventor based in Basel, Switzerland, has made significant contributions to the field of antimicrobial compositions. With one patent to his name, he has demonstrated a strong focus on developing effective solutions to combat microbial infections.
Latest Patents
Dale's notable patent, titled "2-pyridone antimicrobial compositions," introduces a series of 2-pyridone compounds. These compounds serve as a potent and selective new class of type II topoisomerase inhibitors with broad-spectrum antimicrobial activity. They can be utilized in methods for treating infections caused by gram-positive and gram-negative pathogens, as well as drug-resistant strains. The general formula of these compounds allows for modifications, where R1, R2, X, and Y are defined within the patent.
Career Highlights
Currently, Glen Dale is employed at Evolva SA, a company dedicated to creating innovative bio-based solutions. At Evolva, Dale's research and development efforts focus on optimizing these antimicrobial agents to enhance their effectiveness in clinical settings. His work exemplifies the intersection of science and practical application in addressing pressing health concerns.
Collaborations
Throughout his career, Dale has collaborated with notable colleagues, including Patrick Roussel and Jutta Heim. Working alongside these professionals has fostered an environment of innovation and shared knowledge, further propelling advances in antimicrobial research and development.
Conclusion
In summary, Glen Dale stands out as a visionary inventor in the field of antimicrobial compositions. With a significant patent under his belt, his commitment to tackling microbial infections through innovative chemistry is commendable. As the fight against drug-resistant pathogens intensifies, contributions from inventors like Dale are vital in shaping the future of antimicrobial therapy.